NEOGENOMICS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Neogenomics Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Neogenomics Inc Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 128M shares, a 0.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 128M +895K +0.7% Nov 1, 2024 10-Q 2024-11-05
Q2 2024 128M +606K +0.48% Jul 26, 2024 10-Q 2024-07-30
Q1 2024 128M +134K +0.11% Apr 26, 2024 10-Q 2024-04-30
Q4 2023 128M Feb 13, 2024 10-K 2024-02-20
Q3 2023 127M +1.16M +0.92% Nov 2, 2023 10-Q 2023-11-06
Q2 2023 128M +1.76M +1.4% Aug 4, 2023 10-Q 2023-08-08
Q1 2023 128M +2.82M +2.26% May 5, 2023 10-Q 2023-05-09
Q3 2022 126M +3.18M +2.58% Nov 4, 2022 10-Q 2022-11-08
Q2 2022 126M +2.98M +2.43% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 125M +6.83M +5.79% May 6, 2022 10-Q 2022-05-09
Q3 2021 123M +12.1M +10.9% Nov 3, 2021 10-Q 2021-11-04
Q2 2021 123M +12.4M +11.2% Aug 5, 2021 10-Q 2021-08-09
Q1 2021 118M +12.6M +12% May 4, 2021 10-Q 2021-05-06
Q3 2020 111M +6.62M +6.34% Oct 27, 2020 10-Q 2020-10-29
Q2 2020 110M +6.57M +6.33% Jul 28, 2020 10-Q 2020-07-31
Q1 2020 105M +9.99M +10.5% Apr 24, 2020 10-Q 2020-04-29
Q3 2019 104M +11.4M +12.2% Nov 8, 2019 10-Q 2019-11-13
Q2 2019 104M +22.2M +27.2% Aug 2, 2019 10-Q 2019-08-07
Q1 2019 95.3M +14.8M +18.4% May 3, 2019 10-Q 2019-05-08
Q3 2018 93M +12.6M +15.7% Nov 2, 2018 10-Q 2018-11-06
Q2 2018 81.6M +2.25M +2.84% Aug 1, 2018 10-Q 2018-08-06
Q1 2018 80.5M +1.68M +2.14% Mar 5, 2018 10-K 2018-03-13
Q3 2017 80.4M +1.9M +2.42% Nov 7, 2017 10-Q 2017-11-13
Q2 2017 79.4M +1.49M +1.92% Aug 3, 2017 10-Q 2017-08-07
Q1 2017 78.8M +1.71M +2.21% Mar 9, 2017 10-K 2017-03-14
Q3 2016 78.5M +18.2M +30.1% Nov 2, 2016 10-Q 2016-11-07
Q2 2016 77.9M +17.4M +28.7% Aug 3, 2016 10-Q 2016-08-05
Q1 2016 77.1M +16.7M +27.7% Apr 20, 2016 10-Q 2016-05-10
Q3 2015 60.4M +379K +0.63% Nov 2, 2015 10-Q 2015-11-06
Q2 2015 60.5M +10.3M +20.6% Jul 24, 2015 10-Q 2015-07-31
Q1 2015 60.4M +10.7M +21.5% May 5, 2015 10-Q 2015-05-11
Q3 2014 60M +11M +22.5% Oct 31, 2014 10-Q 2014-11-04
Q2 2014 50.2M +1.28M +2.63% Jul 23, 2014 10-Q 2014-07-29
Q1 2014 49.7M +979K +2.01% May 2, 2014 10-Q 2014-05-12
Q3 2013 49M +3.7M +8.18% Oct 25, 2013 10-Q 2013-10-30
Q2 2013 48.9M +3.73M +8.25% Jul 29, 2013 10-Q 2013-08-02
Q1 2013 48.7M +3.87M +8.63% May 6, 2013 10-Q 2013-05-13
Q3 2012 45.3M +2.03M +4.7% Oct 30, 2012 10-Q 2012-11-05
Q2 2012 45.2M +2.07M +4.8% Aug 2, 2012 10-Q/A 2012-08-15
Q1 2012 44.8M Mar 8, 2012 10-K 2012-03-12
Q3 2011 43.2M Oct 21, 2011 10-Q 2011-10-25
Q2 2011 43.1M Jul 22, 2011 10-Q/A 2011-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.